“CRISPR babies” scientist He Jiankui tried to publish a paper describing additional experiments that made heritable changes in the DNA of human embryos, much like those that led to the birth of the world’s first genome-edited humans. But the paper was rejected by an international journal after outside scientists raised concerns about both its ethics and its scientific validity, STAT has learned.

The rejected paper did not report starting a pregnancy with the edited embryos, and “there is no plan” to do so, said Ryan Ferrell, He’s public relations consultant. It is nevertheless one of a tiny handful of experiments editing normal human embryos: A Chinese lab did it in 2017, a U.S. lab followed a few months later, and another Chinese lab did it this summer. And it would make He’s one of only two labs in the world known to have edited human embryos to alter genes for more than one disease.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy